Fair Value Measurements (Details) - USD ($) |
4 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
May 14, 2026 |
|
| Fair Value Measurements [Line Items] | ||
| Over-allotment option liability | $ 197,200 | |
| Price per warrant | $ 11.5 | |
| Public Units [Member] | Underwriters [Member] | ||
| Fair Value Measurements [Line Items] | ||
| Warrant purchases | 3,750,000 | |
| Public Warrants [Member] | IPO [Member] | ||
| Fair Value Measurements [Line Items] | ||
| Price per warrant | $ 0.39 | |
| Warrants issued | $ 3,250,000 |
| X | ||||||||||
- Definition Over-allotment option liability. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|